Compare TENX & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TENX | JRSH |
|---|---|---|
| Founded | 1967 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.1M | 68.8M |
| IPO Year | 2001 | 2017 |
| Metric | TENX | JRSH |
|---|---|---|
| Price | $1.72 | $5.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $9.63 | $6.50 |
| AVG Volume (30 Days) | ★ 2.0M | 93.7K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 485.71 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $166,263,870.00 |
| Revenue This Year | N/A | $14.07 |
| Revenue Next Year | N/A | $7.46 |
| P/E Ratio | ★ N/A | $45.96 |
| Revenue Growth | N/A | ★ 14.03 |
| 52 Week Low | $1.31 | $2.85 |
| 52 Week High | $19.40 | $6.67 |
| Indicator | TENX | JRSH |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 49.87 |
| Support Level | $1.34 | $3.11 |
| Resistance Level | $2.00 | $6.67 |
| Average True Range (ATR) | 0.12 | 0.23 |
| MACD | 0.09 | -0.05 |
| Stochastic Oscillator | 70.91 | 15.84 |
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.